Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Motor Activity 3Breast Neoplasms 3Neoplasms 1Fatigue 1Arthralgia 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × methyl hydroxyethyl cellulose × Breast × Clear all
NCT02682836 2022-01-06

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
60 enrolled
Breast

Breast Neoplasms, Fatigue, Motor Activity

NCT02167932 2018-06-06

The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Completed
127 enrolled
Breast

Breast Neoplasms, Motor Activity, Neoplasms

NCT01900418 2016-08-08

Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy

University of North Carolina, Chapel Hill

Phase NA Completed
78 enrolled
Breast

Breast Neoplasms, Motor Activity, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡